Cancer immunotherapies: advances and bottlenecks.
Rui R, Zhou L, He S.
Front Immunol. 2023 Aug 24;14:1212476. doi: 10.3389/fimmu.2023.1212476. eCollection 2023.
Immunotherapy: a promising approach for glioma treatment.
Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H.
Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023.
Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy.
Pinho SS, Macauley MS, Läubli H.
J Immunother Cancer. 2025 Jun 18;13(6):e012391. doi: 10.1136/jitc-2025-012391.
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, Zhang Z, Yang S, Xiao M.
Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8.
Turning cold tumors into hot tumors by improving T-cell infiltration.
Liu YT, Sun ZJ.
Theranostics. 2021 Mar 11;11(11):5365-5386. doi: 10.7150/thno.58390. eCollection 2021.
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y.
J Hematol Oncol. 2021 Nov 6;14(1):187. doi: 10.1186/s13045-021-01200-4.
Current Immunotherapies for Glioblastoma Multiforme.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H.
Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020.
Colorectal cancer immunotherapy-Recent progress and future directions.
Zhao W, Jin L, Chen P, Li D, Gao W, Dong G.
Cancer Lett. 2022 Oct 1;545:215816. doi: 10.1016/j.canlet.2022.215816. Epub 2022 Jul 8.
Turning cold tumors hot: from molecular mechanisms to clinical applications.
Zhang J, Huang D, Saw PE, Song E.
Trends Immunol. 2022 Jul;43(7):523-545. doi: 10.1016/j.it.2022.04.010. Epub 2022 May 25.
Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
Zhao Y, Shao Q, Peng G.
Cell Mol Immunol. 2020 Jan;17(1):27-35. doi: 10.1038/s41423-019-0344-8. Epub 2019 Dec 18.
